about
sameAs
Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasionThe hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsAldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesisDiscovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequencesCD44 in rheumatoid arthritisVariation in alternative splicing across human tissuesMucin-Type O-Glycosylation in Gastric CarcinogenesisNanogels as imaging agents for modalities spanning the electromagnetic spectrumLiver cancer stem cell markers: Progression and therapeutic implicationsCancer Stem Cell Hierarchy in Glioblastoma MultiformeRoles of Proteoglycans and Glycosaminoglycans in Wound Healing and FibrosisUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliverySAM68: Signal Transduction and RNA Metabolism in Human CancerCollagen VI and hyaluronan: the common role in breast cancerThyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review)Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerThe roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progressionTargeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft ModelDrug and bioactive molecule screening based on a bioelectrical impedance cell culture platform.Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetGlycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migrationHepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actinGlobal profiling and molecular characterization of alternative splicing events misregulated in lung cancer.Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation.CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.Epigenetic deregulation in pediatric acute lymphoblastic leukemia.Brain metastasis-initiating cells: survival of the fittest.Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerBiphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelCD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptorThe role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.Diverse matrix metalloproteinase functions regulate cancer amoeboid migrationCD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasionHigh-throughput binding analysis determines the binding specificity of ASF/SF2 on alternatively spliced human pre-mRNAs.CD44 expression in oro-pharyngeal carcinoma tissues and cell lines
P2860
Q24535552-61CE10E3-D5E6-4CEB-9C8E-DF2C832420CAQ24595836-AC8F061D-8F2C-46BA-BD70-0251C5C780F2Q24645253-62E1D631-16C9-4F91-942F-077071FCCA40Q24682430-F18F6176-9682-4FFC-972F-B3BD3050D7C0Q24804352-F08F05A8-B8DC-43F1-A347-9A4471F12823Q24809417-964705B9-EA90-49DC-AB9D-3871DCBE5158Q26740541-307D9A44-DEAB-4E06-81CB-2E59B917138FQ26741393-5EF5953C-98C6-4B45-941E-FDE32704FACFQ26751026-B1107150-D7AA-4CE5-B1BE-EDAB251379F8Q26752312-124F773B-4271-4F9C-9E8E-F1B7E69CE185Q26786042-F0225A23-B066-4AE4-B8E2-0198830D9424Q26786070-43DC84D8-DD72-40C9-A6B1-2614A399ABE6Q26798149-F3402DDF-2C2C-4CA9-B276-79B6B5BB0B6CQ27011319-48EF9298-A235-4934-9259-44C5E69B4F15Q27015644-8042F529-95C8-4F24-BDB7-735F6F3C1904Q27021261-83832BA0-A955-4592-A3CA-7CA6E9536C30Q27025313-A8465F21-CE83-4700-88A6-AEFA2CA14C35Q27333471-C067D92D-4D32-41B8-8A47-615A4DB5531CQ27691343-6A383D8E-AEB1-4A40-954E-5F3CB16884DCQ28083115-BBBB348A-8874-4180-86BE-D78B23BEB90FQ28251644-1D22B0D9-6F80-418F-A0A6-B384134BCE28Q28574426-F476AFB1-6CBC-4650-ADE0-474346CC2C38Q30497879-02F672EB-5E8B-447B-8036-5612C7A44A6AQ30607164-325FAFD1-9437-492C-87ED-B45CA6970273Q30885646-36E7E296-9D29-465A-B30F-89603ED997ADQ33556551-6475ACE1-47BE-4C57-9138-CF1A3FF1B218Q33582923-98DA845F-AE89-42B4-8E4B-AFCF1B003DF5Q33674704-CC6F3A4D-6848-4860-98FE-8C97505411BDQ33709840-6047259E-BAA5-415C-B7BB-CE6C45109693Q33740709-1D67B7F8-F253-4FD5-BC15-21DCBEB77412Q33755959-EEE19173-4C5F-4F2D-9FED-CB9C14209036Q33855839-FBE9D5E0-7527-4E5D-AF89-C8B0F719594AQ33874532-A0824F88-31B8-4207-A63D-ABBC60053842Q33890100-C6B86832-8FFE-4188-ADDD-DC2A94CB482EQ33924267-A5A39588-D21A-4055-AAE6-27A283F2E53CQ33958763-547CDF38-CFF3-451E-B255-4A9106FCE797Q33988511-844F82D9-D86F-452D-81BC-A0D92091BD8BQ34070561-21D10B40-8601-4653-8C44-1C722A89350DQ34088421-D02AB00F-A72E-4508-99AA-60D8531BC617Q34126560-BBB2A8AC-EA99-42E4-99FA-29CA43334852
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CD44 in cancer
@ast
CD44 in cancer
@en
CD44 in cancer
@nl
type
label
CD44 in cancer
@ast
CD44 in cancer
@en
CD44 in cancer
@nl
prefLabel
CD44 in cancer
@ast
CD44 in cancer
@en
CD44 in cancer
@nl
P2093
P2860
P3181
P1476
CD44 in cancer
@en
P2093
David Naor
Itshak Golan
Lora Melnik
Shlomo Nedvetzki
Yoram Faitelson
P2860
P304
P3181
P356
10.1080/10408360290795574
P407
P577
2002-11-01T00:00:00Z